Cargando…
Celecoxib impairs primary human myoblast proliferation and differentiation independent of cyclooxygenase 2 inhibition
The use of non‐steroidal anti‐inflammatory drugs (NSAIDs) for treatment of musculoskeletal injuries is commonplace in the general, athletic, and military populations. While NSAIDs have been studied in a variety of tissues, the effects of NSAIDs on skeletal muscle have not been fully defined. To addr...
Autores principales: | Matheny, Ronald W., Kolb, Alexander L., Geddis, Alyssa V., Roberts, Brandon M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630763/ https://www.ncbi.nlm.nih.gov/pubmed/36325583 http://dx.doi.org/10.14814/phy2.15481 |
Ejemplares similares
-
The dose–response effects of arachidonic acid on primary human skeletal myoblasts and myotubes
por: Roberts, Brandon M., et al.
Publicado: (2023) -
Differential activation of AKT isoforms by growth factors in human myotubes
por: Roberts, Brandon M., et al.
Publicado: (2023) -
Celecoxib: a selective cyclooxygenase-2 inhibitor
por: Gandelman, M
Publicado: (2003) -
Suppressing growth and invasion of human hepatocellular carcinoma cells by celecoxib through inhibition of cyclooxygenase-2
por: Tai, Yang, et al.
Publicado: (2019) -
[(123)I]-Celecoxib Analogues as SPECT Tracers of Cyclooxygenase-2 in Inflammation
por: Uddin, Md. Jashim, et al.
Publicado: (2010)